Maresin1 Inhibits Ferroptosis via the Nrf2/SLC7A11/GPX4 Pathway to Protect Against Sepsis-Induced Acute Liver Injury [Corrigendum]

Guo Y, Chen H, Sun J, Zhang J, Yin Y. J Inflamm Res. 2024;17:11041—11053.

The authors have advised due to an error that occurred inadvertently at the time of figure assembly, Figure 5C on page 11050 is incorrect. The images of BF and Merge in the Co-culture+LPS+MaR1 column should be interchanged. The correct Figure 5 is as follows.

Figure 5 Continued.

Figure 5 MaR1 activates Nrf2 to suppress ferroptosis. (A and B) Immunofluorescent detection of Nrf2 and Keap1. (C–E) Following ML385 treatment, ROS, iron ion, and lipid peroxide levels in cells were assessed. (F) GPX4 and SLC7A11 expression were detected by Western immunoblotting, n = 3. (G) MDA content. ***p < 0.001.

The authors apologize for this error.

Read the original article

© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.